News

The rocket launch and satellite specialist is growing at an impressive pace.

The telehealth company reported a second-quarter net loss of $86.3 million versus prior-year net income of $42.5 million.

Treasury Secretary Scott Bessent says the U.S. economy is moving beyond the K-shaped divide, but economists and corporate leaders continue to offer mixed views on the health of American consumers. Bessent said in a CNBC "Squawk Box" interview last week...

Costco reported July net sales of $23.12 billion, up 10.7% year-over-year, with comparable sales rising 8.9% overall and 10.3% in the U.S., showing continued strength in its membership-driven model.

This nuclear energy stock has plenty of upside potential.

QUALCOMM (QCOM) shares are back in focus after the company issued fourth quarter 2026 revenue guidance of US$9.7b to US$10.5b, alongside third quarter results showing lower revenue and earnings per share than a year earlier. See our latest analysis for QUALCOMM. QUALCOMM's share price has been volatile around the latest earnings update and guidance, with a 7 day share price return of 6.99% but a 90 day share price return down 22.89%, while the 3 year total shareholder return of 51.80% points...

In August 2026, Studio Mayflower Co., Ltd. launched Monster Battles, a turn-based monster PvP game on Roblox featuring character designs developed with input from Pokémon film director Tetsuo Yajima and ambitions to expand into animation, merchandise, and broader transmedia projects. At the same time, Roblox reported higher Q2 2026 sales of US$1.47 billion with a reduced net loss of US$183 million, while a major institutional investor exited its position citing user engagement challenges and...

Eli Lilly’s updated fair value price target has shifted from US$1,270.37 to US$1,297.31, giving investors a fresh reference point for how analysts are framing the stock today. Much of this reset is tied to recent Street commentary that focuses on incretin and GLP-1 therapies, Q2 results, and the potential of assets like Mounjaro, Zepbound, retatrutide and Foundayo. As you read on, you will see how to track these moving parts and keep up with the evolving Eli Lilly narrative. Stay updated as...

Amid growing doubts about whether the AI infrastructure market is experiencing overbuilding, Wall Street’s largest money managers appear to believe the answer is no. A consortium led by private equity heavyweights, including Apollo Global Management, Blackstone, BlackRock, Brookfield Asset Management, Goldman Sachs and KKR, is working with Nvidia to assemble a $500 billion funding package for AI infrastructure development, the Financial Times reported. The negotiations are the latest signal of t

It was swept up in a broad cybersecurity stock rally.

The air taxi pioneer is making a game-changing acquisition.

(Bloomberg) -- Intel Corp. is seeking to increase the amount it’s raising in a share sale to about $20 billion, according to people familiar with the matter, a third more than it was targeting when it announced the deal Monday morning.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIStocks Churn as Hormuz Standoff Spurs Rally in Oil: Markets WrapIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’GameStop’s Ryan Cohen Weighs Pulling $56 Billio

American Public Education (NASDAQ:APEI) raised its full-year 2026 outlook after reporting second-quarter revenue and adjusted EBITDA that exceeded the high end of its guidance ranges. The company also completed the institutional combination of its education units and announced plans to implement an

AST SpaceMobile (NASDAQ:ASTS) reported second-quarter 2026 revenue of $31.5 million and reiterated its full-year revenue guidance of $150 million to $200 million, as the company continued to build satellites, deploy mobile-network infrastructure and pursue government applications for its space-based

Intel’s stock dropped 4%, weighing on the Nasdaq after announcing a $15 billion stock offering.

Eli Lilly's growth is huge, but on its latest call, analysts tested whether the next chapter can possibly live up to the last one.

Barrick Mining Corp (B) delivers strong Q2 results with gold production beating guidance, a $4 billion Newmont agreement, and $1.5 billion returned to shareholders.

Screens are very useful tools for investors to filter out the noise, allowing for full focus on preferred parameters.

With their number expanding and their quality improving, here are five of the best options trading platforms for investors.

<body><p>STORY: U.S. stocks closed lower on Monday, with the Dow and S&P 500 dipping marginally, and the Nasdaq shedding about a third of a percent.</p><p>Investors became less confident about a deal to reopen the Strait of Hormuz, which sent U.S. crude prices up about 5% to settle at more than $82 a barrel.</p><p>Heightened energy prices have spurred inflation worries and led to concerns that central banks would have to raise interest rates.&nbsp;</p><p>Ryan Isherwood is founder and chief investment officer of Significance Capital Management.</p><p>"Generally speaking, you know, inflationary signs are a reason for investors to take a little bit of a pause — just, you know, take inventory of where things came from. And we think that's just causing, you know, a little bit of normal digestion, if you will, from the recent strong rally."</p><p>:: Intel</p><p>Also weighing on the market were shares of Intel, which fell about 4% after the chipmaker said it was planning to raise $15 billion through a share sale.</p><p>:: Nvidia</p><p>And shares of Nvidia dropped roughly 3%. A person familiar with the matter told Reuters on Monday that a group of financial firms, including Apollo Global and Blackstone, is working with Nvidia to put together a $500 billion funding package for AI infrastructure development.</p><p>And shares of Rocket Lab, down more than 3% at the close, fell further in extended trading after the aerospace company forecast third-quarter gross margin below Wall Street expectations, as sales of lower-margin satellite platforms are set to make up a larger share of its business.</p></body>

Management set a higher bar for profits, and the stock has already jumped, but the real story is how much faster the bottom line is guided to grow than the top line.

The latest analyst takes on the veteran fast food purveyor weren't encouraging.

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Medtronic (NYSE:MDT), meanwhile, continued to […]

Synopsys (NASDAQ:SNPS) just extended its grip on the leading edge of chipmaking. On July 27, at the DAC Chips to Systems Conference, the company said it has certified its AI-powered design software for Intel’s (NASDAQ:INTC) upcoming 14A manufacturing process, building on flows it already runs in production on Intel’s 18A and 18A-P nodes. Bull Case: […]

Shares of digital advertising platform The Trade Desk (NASDAQ:TTD) fell 21.1% in the afternoon session after the company reported a weak second-quarter earnings report and a third-quarter outlook.

Wendy’s posted Q2 results, slashing its dividend and scaling back annual guidance while activist investor Nelson Peltz keeps up the pressure.

Nvidia's $500 billion AI deal has it financing its own chip buyers. Why NVDA stock fell and what analysts see next.

Salesforce stock has fallen to a price floor that has launched powerful rallies before, forcing investors to decide if the company's booming AI business can overcome its current challenges.

Shares of cloud security and performance company Cloudflare (NYSE:NET) jumped 7.7% in the afternoon session after the company reported a massive second-quarter beat-and-raise, driven by a significant acceleration in forward-looking metrics.

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts’ average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The healthcare giant raised its full-year outlook and said it remains on […]